Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Martin

Showing results (571-580 of 654) with videos related to

Pageof 66
Sort By:
Nature Biotechnology|November 24, 2022
Functional analysis of structural variants in single cells using Strand-seqHyobin Jeong, Karen Grimes, Kerstin K Rauwolf, et al.
Cancer Discovery|August 20, 2013
Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphomaThomas Clozel, ShaoNing Yang, Rebecca L Elstrom, et al.
Geburtshilfe Und Frauenheilkunde|March 7, 2025
Early Pregnancy Loss in the 1st Trimester: Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/076; August 2024)Matthias David, Nicolas von Ahsen, Ibrahim Alkatout, et al.
Blood Advances|April 26, 2024
Defining primary refractory large B-cell lymphomaAllison M Bock, Raphael Mwangi, Yucai Wang, et al.
Blood Advances|February 24, 2026
MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphomaJia Ruan, David A Bond, Bijal Shah, et al.
Blood|February 26, 2026
Patient-Derived Lymphoma Spheroids Reveal Predictive Markers of Glofitamab Resistance in Relapsed/Refractory B-NHLPaul Marcoux, Fabien Gava, Marie Tosolini, et al.
Elife|June 19, 2019
Cretaceous dinosaur bone contains recent organic material and provides an environment conducive to microbial communitiesEvan T Saitta, Renxing Liang, Maggie Cy Lau, et al.
Leukemia & Lymphoma|July 21, 2012
Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1Kasyapa S Chitta, Aneel Paulus, Sikander Ailawadhi, et al.
Blood|February 16, 2023
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCLJia Ruan, Alison Moskowitz, Neha Mehta-Shah, et al.
Blood Advances|November 25, 2025
MRD-driven Initial Therapy of Acalabrutinib and Lenalidomide plus Rituximab (ALR) or Obinutuzumab (ALO) for Mantle Cell LymphomaJia Ruan, David A Bond, Bijal D Shah, et al.
Pageof 66

Showing results (571-580 of 654) with videos related to

Sort By:
Pageof 66
Nature Biotechnology|November 24, 2022
Functional analysis of structural variants in single cells using Strand-seqHyobin Jeong, Karen Grimes, Kerstin K Rauwolf, et al.
Cancer Discovery|August 20, 2013
Mechanism-based epigenetic chemosensitization therapy of diffuse large B-cell lymphomaThomas Clozel, ShaoNing Yang, Rebecca L Elstrom, et al.
Geburtshilfe Und Frauenheilkunde|March 7, 2025
Early Pregnancy Loss in the 1st Trimester: Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/076; August 2024)Matthias David, Nicolas von Ahsen, Ibrahim Alkatout, et al.
Blood Advances|April 26, 2024
Defining primary refractory large B-cell lymphomaAllison M Bock, Raphael Mwangi, Yucai Wang, et al.
Blood Advances|February 24, 2026
MRD-driven initial therapy of acalabrutinib and lenalidomide plus rituximab or obinutuzumab for mantle cell lymphomaJia Ruan, David A Bond, Bijal Shah, et al.
Blood|February 26, 2026
Patient-Derived Lymphoma Spheroids Reveal Predictive Markers of Glofitamab Resistance in Relapsed/Refractory B-NHLPaul Marcoux, Fabien Gava, Marie Tosolini, et al.
Elife|June 19, 2019
Cretaceous dinosaur bone contains recent organic material and provides an environment conducive to microbial communitiesEvan T Saitta, Renxing Liang, Maggie Cy Lau, et al.
Leukemia & Lymphoma|July 21, 2012
Development and characterization of a novel human Waldenström macroglobulinemia cell line: RPCI-WM1, Roswell Park Cancer Institute - Waldenström Macroglobulinemia 1Kasyapa S Chitta, Aneel Paulus, Sikander Ailawadhi, et al.
Blood|February 16, 2023
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCLJia Ruan, Alison Moskowitz, Neha Mehta-Shah, et al.
Blood Advances|November 25, 2025
MRD-driven Initial Therapy of Acalabrutinib and Lenalidomide plus Rituximab (ALR) or Obinutuzumab (ALO) for Mantle Cell LymphomaJia Ruan, David A Bond, Bijal D Shah, et al.
Pageof 66